Stocks and Investing
Stocks and Investing
Mon, July 1, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, June 28, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Christopher Raymond Downgraded (BIIB) to Hold and Decreased Target to $250 on, Jun 28th, 2019
Christopher Raymond of Piper Sandler, Downgraded "Biogen Inc." (BIIB) to Hold and Decreased Target from $280 to $250 on, Jun 28th, 2019.
Christopher has made no other calls on BIIB in the last 4 months.
There are 12 other peers that have a rating on BIIB. Out of the 12 peers that are also analyzing BIIB, 9 agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Laura Chico of "Wedbush" Initiated at Hold and Held Target at $231 on, Thursday, May 23rd, 2019
- Geoff Meacham of "Barclays" Maintained at Hold with Decreased Target to $245 on, Thursday, May 9th, 2019
- Carter Gould of "UBS" Downgraded from Strong Buy to Hold on, Friday, March 22nd, 2019
- Robyn Karnauskas of "Citigroup" Downgraded from Strong Buy to Hold and Decreased Target to $230 on, Friday, March 22nd, 2019
- Salim Syed of "Mizuho" Downgraded from Strong Buy to Hold and Decreased Target to $235 on, Friday, March 22nd, 2019
- Sumant Kulkarni of "Canaccord Genuity" Downgraded from Strong Buy to Hold and Decreased Target to $275 on, Friday, March 22nd, 2019
- Alethia Young of "Cantor Fitzgerald" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
- Matt Phipps of "William Blair" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
- Steve Chesney of "Atlantic Equities" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
These are the ratings of the 3 analyists that currently disagree with Christopher
- Evan Seigerman of "Credit Suisse" Initiated at Sell and Held Target at $198 on, Tuesday, May 21st, 2019
- Christopher Marai of "Nomura" Maintained at Strong Buy with Decreased Target to $320 on, Friday, March 22nd, 2019
- Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Sell on, Friday, March 22nd, 2019